BEAM
#1665
Beam Therapeutics Inc. - Common Stock
30.8 9 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.35%
Monthly Change
-0.74%
6 month change
-3.41%
Year Change
+56.33%
Previous Close
31.0 0
Open
30.9 1
Low
30.8 9
High
30.9 1
Volume
189
Financials
- Market Capitalization 3.18 B
- Employee 522
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-48.63
Price to sales ratio
14.54
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1629 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 26.81 USD | -1.14% | -2.05% | +4.44% | +72.41% | 3.35 B USD | ||
| 1657 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.65 USD | +1.38% | -7.94% | +21.20% | +12.49% | 3.22 B USD | ||
| 1672 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 32.03 USD | -3.58% | -9.11% | +25.41% | +16.94% | 3.15 B USD | ||
| 1673 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 51.73 USD | +1.69% | +2.76% | +21.69% | +150.39% | 3.15 B USD |
Frequently asked questions about Beam Therapeutics Inc. - Common Stock
What is the Beam Therapeutics Inc. - Common Stock stock price today?
The current price of Beam Therapeutics Inc. - Common Stock (BEAM) is 30.89. Over the past 24 hours, the stock has changed by -0.35%. Follow the BEAM chart for real-time price dynamics.
What is the stock ticker of Beam Therapeutics Inc. - Common Stock?
Beam Therapeutics Inc. - Common Stock trades under the ticker BEAM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Beam Therapeutics Inc. - Common Stock stock going up?
BEAM has changed by -15.21% over the last week, -0.74% over the last month, and +56.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Beam Therapeutics Inc. - Common Stock release financial reports?
Yes. You can track Beam Therapeutics Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Beam Therapeutics Inc. - Common Stock net income for the last quarter?
Beam Therapeutics Inc. - Common Stock reported net income of -94.32 M for the last quarter. The previous quarter showed 243.36 M, which means net income changed by -138.76%.
How many employees does Beam Therapeutics Inc. - Common Stock have?
As of the latest available data, Beam Therapeutics Inc. - Common Stock has 522 employees. Workforce size can provide additional context about the company's scale and operations.
What is Beam Therapeutics Inc. - Common Stock EBITDA?
Beam Therapeutics Inc. - Common Stock EBITDA is -101.61 M, and its EBITDA margin is -320.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Beam Therapeutics Inc. - Common Stock stock?
You can buy Beam Therapeutics Inc. - Common Stock (BEAM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Beam Therapeutics Inc. - Common Stock stock?
Investing in Beam Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BEAM chart and related analysis on metatrader.com as part of your research.